|Bid||280.0100 x 100|
|Ask||280.9300 x 100|
|Day's range||276.9900 - 282.2700|
|52-week range||178.4400 - 285.7900|
|PE ratio (TTM)||47.88|
|Earnings date||24 Apr. 2018 - 30 Apr. 2018|
|Forward dividend & yield||1.12 (0.40%)|
|1y target est||266.50|
The Cincinnati-based company said it had net income of $3.25 per share. Earnings, adjusted for one-time gains and costs, were $2.32 per share. The operator of the Roto-Rooter plumbing service and Vitas ...
NEW YORK, Jan. 26, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Quidel ...
Investors are apprehensive about the re-enactment of MedTech Tax and related concerns, despite raking in returns from other sectors.
Envision Healthcare continues to suffer from low patient volumes, increased leverage, high operating expense and a weak operating environment.
We have considered four popular ratios in order to find efficient companies that have the potential to provide impressive returns
In the wake of the volatile political scenario and taking a few favorable metrics into account, these MedTech stocks stand out as the most suitable picks.
Chemed (CHE) continues to display robust performance in Roto-Rooter business on strength in core plumbing and drain cleaning service segments.
Rising demand for InvisAlign products in the global teen market and the distribution agreement with Patterson Dental are major upsides for Align (ALGN).
Zacks.com highlights: Chemed, Baxter International, IDEXX Laboratories, Advanced Energy Industries and Pioneer Natural Resources
Company with a favorable efficiency level generally provides impressive returns as it is believed to be positively correlated with the stock's price performance.
Chemed (CHE) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.